Benaroya Research Institute
The Long Lab at Benaroya Research Institute seeks a motivated postdoctoral researcher to study immune mechanisms driving type 1 diabetes and other autoimmune diseases using advanced human immunology, single‑cell, and systems approaches. The role involves designing and executing independent projects, analyzing complex datasets, and collaborating with multidisciplinary teams across BRI, the University of Washington, and TrialNet.
Headquarters
Seattle, Washington, United States
Company Size
201-500 employees
Founded
1956
Benaroya Research Institute (BRI) is a Seattle-based nonprofit biomedical research institute dedicated to understanding the immune system and developing new treatments for autoimmune, immune-mediated and inflammatory diseases. Research is organized into Centers of Discovery—Fundamental, Translational, Interventional and Systems Immunology—combining basic science, bioinformatics and clinical translation. BRI’s multidisciplinary faculty advance biomarkers, therapies and clinical trials through partnerships with hospitals, industry and patient communities. The institute focuses on moving discoveries from the lab to the clinic to improve diagnosis, prevention and treatment.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Benaroya Research Institute.
15% above the average for this role
Postdoctoral Researcher
La Jolla Institute for Immunology
Postdoctoral Research Fellow
Eli Lilly and Company
Postdoctoral Research Fellow
Nanyang Technological University
Postdoctoral Research Associate - Immunology
St. Jude Children's Research Hospital
Postdoctoral Fellow
UMB AG
Associate Scientist -Molecular Immunology - VIE Contract
Sanofi